NCT00667056View on ClinicalTrials.gov

Study of the Safety and Efficacy of Tacrolimus Ointment in Treating Chronic Allergic Contact Dermatitis

PHASE4CompletedINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

December 31, 2004

Study Completion Date

December 31, 2004

Conditions
Dermatitis
Interventions
DRUG

tacrolimus ointment

topical

DRUG

placebo ointment

topical

Trial Locations (10)

10016

New York

17033

Hershey

20037

Washington D.C.

24501

Lynchburg

40202

Louisville

55417

Minneapolis

66160

Kansas City

66216

Shawnee

70121

New Orleans

97239

Portland

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT00667056 - Study of the Safety and Efficacy of Tacrolimus Ointment in Treating Chronic Allergic Contact Dermatitis | Biotech Hunter | Biotech Hunter